Stemline Therapeutics reported U$12345 in Trade Debtors for its first quarter of 2020.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Trade Debtors Change
Abbvie U$ 8354M 1992M
Agenus U$ 16.628M 13.985M
Amgen U$ 5366M 357M
Biocryst Pharmaceuticals U$ 3M 2M
Bristol Myers Squibb U$ 7855M 435M
Celldex Therapeutics U$ 0M 1M
Daiichi Sankyo Y 243887M 65476M
Eisai Y 183991M 3969M
GlaxoSmithKline 749600000 139900000
Halozyme Therapeutics U$ 37.401M 7.652M
Immunogen U$ 15.439M 0.335M
JAZZ PHA U$ 361.664M 9.744M
Macrogenics 19205000 7399000
Merk U$ 7577M 605M
Novartis 7952000000 843000000
Pfizer U$ 9128M 753M
Seattle Genetics U$ 290.074M 65.461M
Stemline Therapeutics U$ 12M 3M
Sumitomo Dainippon Y 144802M 4434M
United Therapeutics U$ 172M 22.4M
Verastem U$ 1M 2M